E-COMMODITIES (01733) signed a counter-guarantee contract with Xiangyu Stock.
Easily Bulk (01733) announced that on December 16, 2024, Xianghui Singapore (a wholly owned subsidiary of Xianghui Energy...
E-COMMODITIES (01733) announced that on December 16, 2024, Xiang Hui Singapore (a wholly-owned subsidiary of Xiang Hui Energy) signed a master agreement with designated Bank A for foreign exchange derivative transactions (including forward exchange transactions, options, swaps, etc.). In relation to the transactions intended under the master agreement, Xiangyu Holdings agrees to provide a corporate guarantee to Bank A in an amount not exceeding approximately $7 million USD and to sign a bank guarantee contract to ensure that Xiang Hui Singapore fulfills its responsibilities and obligations under the master agreement. Xiang Hui Energy is held 49% by the company and 51% by Xiangyu Holdings.
On January 17, 2025, the company and Xiangyu Holdings entered into a counter-guarantee contract I, where the company agrees to provide a counter-guarantee I in an amount not exceeding approximately $3.773 million USD to Xiangyu Holdings in proportion to their 49% ownership in Xiang Hui Energy under bank guarantee contract I, including any guarantee amounts, accrued interest, default penalties, compensation, and other related expenses.
To further expand the coal trading business, the parties involved in the contract provide sufficient operational funding support to Xiang Hui Energy through counter-guarantees and arrangements in the related transaction documents.
Related Articles

Suzhou Chunqiu Electronic Technology (603890.SH) shareholders plan to reduce their holdings by no more than 0.74% of the shares.

Shanghai Yct Electronics Group (301099.SZ) intends to launch a restricted stock incentive plan in 2025.

Goldman Sachs Group, Inc. has raised the target price of Agios (AGIO.US) to 28 dollars, bullish on the prospects of the new drug Aqvesme for Mediterranean anemia.
Suzhou Chunqiu Electronic Technology (603890.SH) shareholders plan to reduce their holdings by no more than 0.74% of the shares.

Shanghai Yct Electronics Group (301099.SZ) intends to launch a restricted stock incentive plan in 2025.

Goldman Sachs Group, Inc. has raised the target price of Agios (AGIO.US) to 28 dollars, bullish on the prospects of the new drug Aqvesme for Mediterranean anemia.

RECOMMEND

Not Just “Power Shortages,” Delays Will Become The Key Theme For U.S. Data Centers In 2026
26/12/2025

Hang Seng Index Rises 33% This Year, Best Five‑Year Performance; Multiple Institutions Forecast Breakthrough Above 30,000 Next Year
26/12/2025

Gold Rally Has Further To Run, JPMorgan Bullish: Prices Could Reach USD 5,055 By Year‑End 2026
26/12/2025


